Back
Franklin U.S. Low Volatility Hi Div ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
45
LVHD
Franklin U.S. Low Volatility Hi Div ETF
Last Price:
39.86
Seasonality Move:
2.53%
Sell
39
HALO
Halozyme Therapeutics
Last Price:
45.65
Seasonality Move:
17.03%
Sell
45
Franklin U.S. Low Volatility Hi Div ETF (LVHD)
is a Sell
Is Franklin U.S. Low Volatility Hi Div ETF a Buy, Sell or Hold?
- The current Franklin U.S. Low Volatility Hi Div ETF [LVHD] share price is $39.86. The Score for LVHD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- LVHD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LVHD Stock Price Chart
What is Franklin U.S. Low Volatility Hi Div ETF's stock price today?
-
The Franklin U.S. Low Volatility Hi Div ETF share price today is $39.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LVHD is experiencing slight selling pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
LVHD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 44.71 | Sell |
Chaikin Money Flow: | -5734 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.83 - 40.81) | Sell |
Bollinger Bands (100): | (37.58 - 40.72) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 30.2 | Sell |
Chaikin Money Flow: | -7140517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.94 - 58.56) | Sell |
Bollinger Bands (100): | (52.16 - 60.38) | Sell |
LVHD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.11 | Sell |
20-day SMA: | 40.14 | Sell |
50-day SMA: | 40.35 | Sell |
200-day SMA: | 37.48 | Buy |
8-day EMA: | 40.05 | Sell |
20-day EMA: | 40.14 | Sell |
50-day EMA: | 40 | Sell |
200-day EMA: | 38.16 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.53 | Sell |
20-day SMA: | 54.48 | Sell |
50-day SMA: | 56.18 | Sell |
200-day SMA: | 48.93 | Sell |
8-day EMA: | 55 | Sell |
20-day EMA: | 55.41 | Sell |
50-day EMA: | 55.64 | Sell |
200-day EMA: | 50.73 | Sell |
Franklin U.S. Low Volatility Hi Div ETF Earnings Growth & LVHD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.
Franklin U.S. Low Volatility Hi Div ETF Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |